Andrew Payne

628 total citations
22 papers, 408 citations indexed

About

Andrew Payne is a scholar working on Physiology, Molecular Biology and Oncology. According to data from OpenAlex, Andrew Payne has authored 22 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Andrew Payne's work include Salivary Gland Disorders and Functions (3 papers), Obesity, Physical Activity, Diet (3 papers) and Physical Activity and Health (3 papers). Andrew Payne is often cited by papers focused on Salivary Gland Disorders and Functions (3 papers), Obesity, Physical Activity, Diet (3 papers) and Physical Activity and Health (3 papers). Andrew Payne collaborates with scholars based in United Kingdom, United States and Italy. Andrew Payne's co-authors include Peter Koulen, Simon Kaja, James M. A. Turner, John Porter, Colin Stubberfield, Brian Hutchinson, Daniel Ford, Jeremy Davis, Graham Trevitt and Ian Whitcombe and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Andrew Payne

22 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Payne United Kingdom 11 151 76 69 62 46 22 408
Rosalba Florio Italy 16 329 2.2× 116 1.5× 41 0.6× 34 0.5× 102 2.2× 26 530
Robert W. Tuman United States 14 300 2.0× 104 1.4× 35 0.5× 25 0.4× 90 2.0× 27 588
Etsuko Negishi Japan 12 245 1.6× 41 0.5× 45 0.7× 74 1.2× 30 0.7× 23 432
V. Monzani Italy 7 277 1.8× 22 0.3× 39 0.6× 23 0.4× 74 1.6× 11 433
Juan Molina-Güarneros Mexico 12 152 1.0× 93 1.2× 21 0.3× 16 0.3× 42 0.9× 30 446
Yang Tang China 5 215 1.4× 93 1.2× 24 0.3× 42 0.7× 46 1.0× 8 357
Michael S. Cosgrove United States 11 350 2.3× 17 0.2× 40 0.6× 30 0.5× 33 0.7× 19 563
Elisabet Wieslander Sweden 16 257 1.7× 36 0.5× 183 2.7× 87 1.4× 57 1.2× 25 720
Nikolaos Lougiakis Greece 10 164 1.1× 142 1.9× 139 2.0× 53 0.9× 30 0.7× 37 447
D M Mock United States 13 165 1.1× 107 1.4× 38 0.6× 21 0.3× 25 0.5× 25 617

Countries citing papers authored by Andrew Payne

Since Specialization
Citations

This map shows the geographic impact of Andrew Payne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Payne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Payne more than expected).

Fields of papers citing papers by Andrew Payne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Payne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Payne. The network helps show where Andrew Payne may publish in the future.

Co-authorship network of co-authors of Andrew Payne

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Payne. A scholar is included among the top collaborators of Andrew Payne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Payne. Andrew Payne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Payne, Andrew, et al.. (2024). 218 (PB206): Combining next-generation BTK and MALT1 inhibitors to enhance efficacy and therapeutic utility in B-cell malignancies. European Journal of Cancer. 211. 114736–114736. 1 indexed citations
2.
Okumura, Ryota, Venu Thatikonda, Giuseppe Fiume, et al.. (2023). 2289P Determining anti-cancer efficacy of a reversible LSD1 inhibitor, EXS74539, in primary AML tissues with limited thrombocytopenic effects. Annals of Oncology. 34. S1173–S1173. 1 indexed citations
3.
Gooyit, Major, Andrew Payne, Dean B. Evans, et al.. (2023). 832P Characterisation of EXS73565: A potent and selective MALT1 inhibitor with low drug-drug interaction risk and potential in lymphoma. Annals of Oncology. 34. S546–S547. 1 indexed citations
4.
Fons, Pierre, Mark Whittaker, Klaus Hackner, et al.. (2022). Abstract 4150: Enriching for adenosine antagonist patient responses through deep learning. Cancer Research. 82(12_Supplement). 4150–4150. 1 indexed citations
5.
Chen, Sijia, Ross A. Paveley, Elizabeth Stevens, et al.. (2020). Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases. Journal of Autoimmunity. 111. 102435–102435. 26 indexed citations
6.
Juárez, Maria, Nieves Díaz, Geoffrey I. Johnston, et al.. (2019). AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME (PSS). Annals of the Rheumatic Diseases. 78. 1692–1693. 3 indexed citations
7.
Nayar, Saba, Joana Campos, Charlotte G. Smith, et al.. (2018). Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome. Annals of the Rheumatic Diseases. 78(2). 249–260. 37 indexed citations
8.
Allen, Rodger A., Mark Powell, Gareth Davies, et al.. (2017). Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3Kδ. Journal of Pharmacology and Experimental Therapeutics. 361(3). 429–440. 35 indexed citations
9.
Helmer, Eric, Mark Watling, Emma Jones, et al.. (2017). First-in-human studies of seletalisib, an orally bioavailable small-molecule PI3Kδ inhibitor for the treatment of immune and inflammatory diseases. European Journal of Clinical Pharmacology. 73(5). 581–591. 13 indexed citations
10.
Nayar, Saba, et al.. (2016). A7.07 Phosphatidylinositol 3–kinase delta pathway a novel therapeutic target for sjoegren's syndrome. Annals of the Rheumatic Diseases. 75. A58–A58. 3 indexed citations
11.
Payne, Andrew, et al.. (2014). Antioxidant Drug Therapy Approaches for Neuroprotection in Chronic Diseases of the Retina. International Journal of Molecular Sciences. 15(2). 1865–1886. 55 indexed citations
12.
Kaja, Simon, et al.. (2014). Resveratrol and Calcium Signaling: Molecular Mechanisms and Clinical Relevance. Molecules. 19(6). 7327–7340. 63 indexed citations
13.
Ismail, Waidah, Rosline Hassan, Andrew Payne, & Stephen Swift. (2011). The detection and classification of blast cell in Leukaemia Acute Promyelocytic Leukaemia (AML M3) blood using simulated annealing and neural networks. Physiotherapy Theory and Practice. 28(1). 71–83. 2 indexed citations
14.
Porter, John, Andrew Payne, Ian Whitcombe, et al.. (2009). Atropisomeric small molecule Bcl-2 ligands: Determination of bioactive conformation. Bioorganic & Medicinal Chemistry Letters. 19(6). 1767–1772. 28 indexed citations
15.
Bulley, Catherine, Marie Donaghy, Andrew Payne, & Nanette Mutrie. (2009). Personal Meanings, Values and Feelings Relating to Physical Activity and Exercise Participation in Female Undergraduates. Journal of Health Psychology. 14(6). 751–760. 12 indexed citations
16.
Porter, John, Andrew Payne, Daniel Ford, et al.. (2008). Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(1). 230–233. 86 indexed citations
17.
Bulley, Catherine, Marie Donaghy, Andrew Payne, & Nanette Mutrie. (2008). Stages of exercise behaviour change: A pilot study of measurement validity. International Journal of Health Promotion and Education. 46(1). 4–10. 3 indexed citations
18.
Bulley, Catherine, Marie Donaghy, Andrew Payne, & Nanette Mutrie. (2005). Validation and modification of the Scottish Physical Activity Questionnaire for use in a female student population. International Journal of Health Promotion and Education. 43(4). 117–124. 4 indexed citations
19.
Payne, Andrew. (1999). Some views of representatives of the South African fishing industry about local fisheries management. ICES Journal of Marine Science. 56(6). 1067–1072. 3 indexed citations
20.
Abboud, Miguel R., Fushen Xu, Andrew Payne, & Joseph Laver. (1994). Effects of recombinant human Steel factor (c-kit ligand) on early cord blood hematopoietic precursors.. PubMed. 22(4). 388–92. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosalba Florio Breakdown of academic impact, for papers by Robert W. Tuman Breakdown of academic impact, for papers by Etsuko Negishi Breakdown of academic impact, for papers by V. Monzani Breakdown of academic impact, for papers by Juan Molina-Güarneros Breakdown of academic impact, for papers by Yang Tang Breakdown of academic impact, for papers by Michael S. Cosgrove Breakdown of academic impact, for papers by Elisabet Wieslander Breakdown of academic impact, for papers by Nikolaos Lougiakis Breakdown of academic impact, for papers by D M Mock
Rankless by CCL
2026